DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

References

Erlinge D, James S, Duvvuru S. , et al.
Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.

Thromb Haemost 2014;
111 (05) 943-950

Erlinge D, James S, Duvvuru S. , et al.
Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.

Thromb Haemost 2014;
111 (05) 943-950

Download Bibliographical Data

Search in:
Access: